Potentiating the antitumor effects of chemotherapy with the selective PI3K inhibitor XL147

被引：0
|
作者：
Foster, Paul G. [1 ]
机构：
[1] Exelixis Inc, San Francisco, CA USA
来源：
MOLECULAR CANCER THERAPEUTICS | 2007年 / 6卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3592S / 3592S
页数：1
相关论文
共 50 条
  • [31] Pi3kδ Inhibitor Pulmonary Toxicity
    Bender, M. T.
    Sanso, L. M.
    Narula, N.
    Harvey, B-G.
    Kaner, R. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [32] Antitumor Activity of Tipifarnib and PI3K Pathway Inhibitor in HRAS-associated HNSCC
    Smith, A.
    Chan, S.
    McCloskey, A.
    Vora, H.
    Burrows, F.
    Malik, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 112 (05): : E48 - E48
  • [33] VS-5584, a PI3K/mTOR dual inhibitor, exerts antitumor effects on neuroblastomas in vitro and in vivo
    Chen, Yun
    Tsai, Huang-Wen
    Tsai, Ya-Hui
    Tseng, Sheng-Hong
    JOURNAL OF PEDIATRIC SURGERY, 2021, 56 (08) : 1441 - 1448
  • [34] In vitro assessment of antitumor activities of the PI3K/mTOR inhibitor GSK2126458
    Alia Albawardi
    Muna Al Ayyan
    Mohamed Al Bashir
    Abdul-Kader Souid
    Saeeda Almarzooqi
    Cancer Cell International, 14
  • [35] In vitro assessment of antitumor activities of the PI3K/mTOR inhibitor GSK2126458
    Albawardi, Alia
    Al Ayyan, Muna
    Al Bashir, Mohamed
    Souid, Abdul-Kader
    Almarzooqi, Saeeda
    CANCER CELL INTERNATIONAL, 2014, 14
  • [36] Designing selective PI3K inhibitors
    Crunkhorn, Sarah
    NATURE REVIEWS DRUG DISCOVERY, 2010, 9 (02) : 105 - 105
  • [37] Designing selective PI3K inhibitors
    Sarah Crunkhorn
    Nature Reviews Drug Discovery, 2010, 9 : 105 - 105
  • [38] Discovery of AZD8835, a potent and selective inhibitor of PI3Kα and PI3Kδ for the treatment of PIK3CA-dependent cancers
    Barlaam, Bernard
    Cosulich, Sabina
    Delouvrie, Benedicte
    Fitzek, Martina
    Germain, Herve
    Green, Stephen
    Harris, Craig S.
    Hudson, Kevin
    Lambert-van der Brempt, Christine
    Lamorlette, Maryannick
    Antoine, Le Griffon
    Morgentin, Remy
    Ouvry, Gilles
    Page, Ken
    Pasquet, Georges
    Ruston, Linette
    Saleh, Twana
    Vautier, Michel
    Ward, Lara
    CANCER RESEARCH, 2015, 75
  • [39] Effects of AS2541019, a novel selective PI3Kδ inhibitor, on antibody production and hamster to rat xenotransplantation
    Marui, Takanori
    Fukahori, Hidehiko
    Kawashima, Tomoko
    Ito, Misato
    Akamatsu, Masahiko
    Kaneko, Yoko
    Takahashi, Fumie
    Imada, Sunao
    Morokata, Tatsuaki
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2018, 826 : 179 - 186
  • [40] Initial testing (stage 1) of the phosphatidylinositol 3 kinase inhibitor, SAR245408 (XL147) by the pediatric preclinical testing program
    Reynolds, C. Patrick
    Kang, Min H.
    Carol, Hernan
    Lock, Richard
    Gorlick, Richard
    Kolb, E. Anders
    Kurmasheva, Raushan T.
    Keir, Stephen T.
    Maris, John M.
    Billups, Catherine A.
    Houghton, Peter J.
    Smith, Malcolm A.
    PEDIATRIC BLOOD & CANCER, 2013, 60 (05) : 791 - 798
12345